Industry leaders point to three areas causing particular concern for businesses, including cyber risks.
Top executives in the pharmaceutical and life sciences industry have higher expectations for growth in their own companies than senior executives from other industries, according to the 2026 CEO Survey by consulting and auditing firm PwC.
Related articles
Subscription
Sonova lowers full-year forecast and announces sale of headset business
UBS says Novo Nordisk’s prescription figures look promising
You need to be a subscriber to read the rest of the article.